# Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

> **NCT03987711** · PHASE2 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 151 (actual)

## Conditions studied

- Atrial Fibrillation
- End Stage Renal Failure on Dialysis

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Apixaban
- **OTHER:** No oral anticoagulation

## Key facts

- **NCT ID:** NCT03987711
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03987711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03987711, "Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT03987711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*